Skip to main content
. 2019 Jan 21;100(3):630–634. doi: 10.4269/ajtmh.18-0672

Table 2.

Characteristics of DHF hospitalization (n = 25)*

Dengue grade (adjusted WHO 1997; n, %)
 Dengue fever 0 (0)
 Dengue hemorrhagic fever grade I 6 (24)
 Dengue hemorrhagic fever grade II 5 (20)
 Dengue hemorrhagic fever grade III (DSS) 7 (28)
 Dengue hemorrhagic fever grade IV (DSS) 7 (28)
Dengue grade (WHO 2009; n, %)
 Dengue fever without warning signs 1 (4)
 Dengue fever with warning signs 10 (40)
 Severe dengue 14 (56)
Age at hospitalization (years) 6.9 (2.8–8.8)
Time between hospitalization and current measurements (years) 8.4 (0.8–16.5)
Duration of hospitalization (days) 4.4 (3–8)
Presence of plasma leakage (n, %) 22 (88)
Presence of mucosal bleeding manifestations (n, %) 4 (16)
Presence of gastrointestinal bleeding manifestations (n, %) 3 (12)
Presence of dermal bleeding manifestations (n, %) 12 (48)
Presence of pleural effusion (n, %) 4 (16)
Presence of encephalopathy (n, %) 1 (4)
Presence of other severe complications (n, %)† 3 (12)
Presence of dengue IgM antibodies (%) 56
Presence of dengue IgG antibodies (%) 80
Mean lowest recorded hematocrit (%)‡ 32.6 (16.6–45.3)
Mean highest recorded hematocrit (%)‡ 43.6 (30.0–56.0)
Mean ∆-hematocrit (%)‡,§ 39.7 (4.9–123.8)
Mean lowest recorded thrombocyte count (cells/µL)‡ 42,929 (6,000–89,000)
Mean highest recorded thrombocyte count (cells/µL)‡ 98,088 (44,100–206,000)
Mean ∆-thrombocyte count (%)‡,§ 225.8 (14.6–1,250.0)
Mean highest recorded leukocyte count (cells/mm3) 13,468 (3,300–127,000)
Mean lowest systolic blood pressure (mmHg) 97.9 (70–120)
Mean lowest diastolic blood pressure (mmHg) 58.0 (32–80)
Mean lowest mean arterial pressure (mmHg) 71.3 (50–93)
Crystalloid fluid management (%)
 Maintenance (Ringer’s lactate) 6 (24)
 Maintenance (dextrose + NaCl) 2 (8)
 10% rehydration deficit (Ringer’s lactate) 17 (68)
Presence of colloid transfusion (%) 5 (20)

DHF = dengue hemorrhagic fever; DSS = dengue shock syndrome. All values are mean (range), unless otherwise indicated.

* Clinical data on the hospitalization period were not available for three participants and these are, therefore, not included in this table.

† Three of 25 participants had renal impairment as a complication of DHF.

‡ One participant had only one reported value of hematocrit and thrombocyte count and is not included in the mean data of those parameters, but is included in the other parameters.

§ Expressed as “(highest value–lowest value)/lowest value * 100%.”